Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2022 | Diagnostic tools for neurodegenerative disease

Davide Tampellini, PhD, U1195 INSERM Institute Baulieu, Paris, France, speaks on the importance of diagnostic tools for neurodegenerative disease, particularly the development of cerebrospinal fluid, blood, and MRI biomarkers. Discriminating between different types of dementia, such as Alzheimer’s disease, frontotemporal dementia, and Lewy body dementia, is important to monitor patients and their treatment. This interview took place at the AD/PD™ 2022 Conference in Barcelona, Spain.

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.